New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.

Merker VL, Ahlawat S, Avery RA, Bradford D, Gross AM, Janusz J, Lessing AJ, Manth L, McManus ML, Oberlander B, Pichard DC, Riter W, Sarin KY, Sheard S, Sundby RT, Walsh KS, Wolters PL, Widemann BC, Plotkin SR

Open source

DOI: 10.3390/cancers18152463
Published: 2026 Jul 31
Container: Cancers
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/cancers18152463,
  title = {New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.},
  author = {Merker VL and Ahlawat S and Avery RA and Bradford D and Gross AM and Janusz J and Lessing AJ and Manth L and McManus ML and Oberlander B and Pichard DC and Riter W and Sarin KY and Sheard S and Sundby RT and Walsh KS and Wolters PL and Widemann BC and Plotkin SR},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18152463},
  url = {https://doi.org/10.3390/cancers18152463}
}

RIS

TY  - JOUR
TI  - New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.
AU  - Merker VL
AU  - Ahlawat S
AU  - Avery RA
AU  - Bradford D
AU  - Gross AM
AU  - Janusz J
AU  - Lessing AJ
AU  - Manth L
AU  - McManus ML
AU  - Oberlander B
AU  - Pichard DC
AU  - Riter W
AU  - Sarin KY
AU  - Sheard S
AU  - Sundby RT
AU  - Walsh KS
AU  - Wolters PL
AU  - Widemann BC
AU  - Plotkin SR
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18152463
UR  - https://doi.org/10.3390/cancers18152463
ER  -

APA

VL, M., S, A., RA, A., D, B., AM, G., J, J., AJ, L., L, M., ML, M., B, O., DC, P., W, R., KY, S., S, S., RT, S., KS, W., PL, W., BC, W., & SR, P. (2026). New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.. Cancers. https://doi.org/10.3390/cancers18152463

Source records

pubmed · retrieved 2026-09-25T13:04:09.366Z